Indication
Staphylococcal pharyngitis
Staphylococcal pharyngitis is an uncommon bacterial infection of the upper respiratory tract, specifically involving inflammation of the pharyngeal mucosa and tonsillar tissue caused by *Staphylococcus* species, most notably *Staphylococcus aureus*. Read more about Staphylococcal pharyngitis
47 drugs 33 manufacturers
Drugs that treat it
Common Staphylococcal pharyngitis therapies.
AMOXICILLIN
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonStaphylococcal pharyngitis is an uncommon bacterial infection of the upper respiratory tract, specifically involving inflammation of the pharyngeal mucosa and tonsillar tissue caused by *Staphylococcus* species, most notably *Staphylococcus aureus*.
Affecting pediatric and adult populations, the condition occurs when colonizing or acquired staphylococcal bacteria overcome local mucosal defenses, leading to tissue invasion or toxin production.
Defining clinical and pathophysiologic features include acute throat pain, mucosal erythema, tonsillar exudates, fever, and cervical lymphadenopathy, with potential risk for local suppurative spread or toxin-mediated systemic manifestations such as toxic shock syndrome.
Distinguishing true infection from benign mucosal carriage requires careful clinical correlation alongside microbiological confirmation.
- nih.gov
Staphylococcal pharyngitis is an uncommon bacterial infection of the upper respiratory tract, specifically involving inflammation of the pharyngeal mucosa and tonsillar tissue caused by *Staphylococcus* species, most notably *Staphylococcus aureus*
- nih.gov
Staphylococcal pharyngitis is an uncommon bacterial infection of the upper respiratory tract, specifically involving inflammation of the pharyngeal mucosa and tonsillar tissue caused by *Staphylococcus* species, most notably *Staphylococcus aureus* Affecting pediatric and adult populations, the condition occurs when colonizing or acquired staphylococcal bacteria overcome local mucosal defenses, leading to tissue invasion or toxin production Distinguishing true infection from benign mucosal carri...
- cdc.gov
Affecting pediatric and adult populations, the condition occurs when colonizing or acquired staphylococcal bacteria overcome local mucosal defenses, leading to tissue invasion or toxin production Defining clinical and pathophysiologic features include acute throat pain, mucosal erythema, tonsillar exudates, fever, and cervical lymphadenopathy, with potential risk for local suppurative spread or toxin-mediated systemic manifestations such as toxic shock syndrome
- semanticscholar.org
Defining clinical and pathophysiologic features include acute throat pain, mucosal erythema, tonsillar exudates, fever, and cervical lymphadenopathy, with potential risk for local suppurative spread or toxin-mediated systemic manifestations such as toxic shock syndrome
- consultant360.com
Defining clinical and pathophysiologic features include acute throat pain, mucosal erythema, tonsillar exudates, fever, and cervical lymphadenopathy, with potential risk for local suppurative spread or toxin-mediated systemic manifestations such as toxic shock syndrome
- nih.gov
Distinguishing true infection from benign mucosal carriage requires careful clinical correlation alongside microbiological confirmation
Personalize your experience
Follow Staphylococcal pharyngitis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.